Challenges in Exploiting Human H Ferritin Nanoparticles for Drug Delivery: Navigating Physiological Constraints
2024

Challenges in Using Ferritin Nanoparticles for Drug Delivery

publication Evidence: moderate

Author Information

Author(s): Macone Alberto, Cappelletti Chiara, Incocciati Alessio, Piacentini Roberta, Botta Sofia, Boffi Alberto, Bonamore Alessandra

Primary Institution: Department of Biochemical Sciences 'Alessandro Rossi Fanelli' Sapienza University of Rome

Hypothesis

What are the physiological constraints that hinder the clinical application of ferritin nanoparticles for drug delivery?

Conclusion

Ferritin nanoparticles have potential for drug delivery, but significant challenges related to their physiological effects and biodistribution must be addressed before clinical use.

Supporting Evidence

  • Ferritin nanoparticles can encapsulate a variety of therapeutic agents.
  • Clinical advancements in ferritin-based drug delivery systems have not yet been fully realized.
  • Understanding the biodistribution of ferritin is crucial for its application in medicine.
  • Ferritin's natural accumulation in organs can lead to off-target effects.
  • Surface modifications can alter the biodistribution and targeting properties of ferritin nanoparticles.

Takeaway

Ferritin nanoparticles can help deliver medicine to the right places in the body, but we need to understand how they work in our bodies better before using them in hospitals.

Potential Biases

Potential immune responses to ferritin nanoparticles may vary based on their surface modifications and the presence of contaminants.

Limitations

Most studies have been conducted in mice, which may not accurately reflect human responses, and the effects of ferritin on cellular metabolism are not fully understood.

Digital Object Identifier (DOI)

10.1002/wnan.2016

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication